Robert Burnside

Statistics

Publications

Citations

186

H-Index

Active since

1988

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

University of Alabama at Birmingham

Robert Burnside is an author at Pfizer (United States) specializing in antiviral safety assessment, antiretroviral therapy, and antiviral pharmacotherapy.

Publications per year

1988–2013

Publications

Efficacy and Safety of Maraviroc Versus Efavirenz, Both With Zidovudine/Lamivudine: 96-Week Results From the MERIT Study

Juan Sierra‐Madero, Giovanni Di Perri, Robin Wood et al. · HIV Clinical Trials · 2010 · 65 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Five-Year Safety Evaluation of Maraviroc in HIV-1–Infected Treatment-Experienced Patients

Roy M. Gulick, Gerd Fätkenheuer, Robert Burnside et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 45 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1

David A. Cooper, Jayvant Heera, Prudence Ive et al. · AIDS · 2013 · 37 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

User's Guide for KEYS: Assessing the Climate for Creativity

Teresa M. Amabile, Robert Burnside, Stanley S. Gryskiewicz · 1995 · 21 citations

Management, Organizational Behavior, Creative Problem Solving +8

Assessing Organizational Climates for Creativity and Innovation: Methodological Review of Large Company Audits

Robert Burnside, Teresa M. Amabile, Stanley S. Gryskiewicz · 1988 · 18 citations

Management, Organization Studies, Organizational Behavior +16

1–5 of 5